Sort   by:  
 Page size 
Not available
ORGANISM(S): Bacteroides spp. and Escherichia spp. (mixed communities) 

Bacteria in the gut can modulate the availability and efficacy of therapeutic drugs. Interactions at this level have only recently started to being systematically mapped and the main underlying mechanism proposed is chemical transformation of drugs by microbes (biotransformation). Here, we invest...

2021-07-20 | MTBLS1792 | MetaboLights

Background: The use of sulfonamides (SAs) caused residual pollution in the environment. Bacteria play an important role in the degradation of sulfonamide antibiotics, and microbial consortium offers advantages over single bacterium. However, the complex degradation process and interaction mechani...

2024-11-08 | MTBLS11473 | MetaboLights
Cross-feeding is fundamental to the diversity and function of microbial communities. However, identification of cross-fed metabolites is often challenging due to the universality of metabolic and biosynthetic intermediates. Here, we use 13C isotope tracing in peptides to elucidate cross-fed metaboli...
ORGANISM(S): Saccharomyces cerevisiae (Baker's yeast) 
2023-02-07 | PXD019952 | Pride
Quantifying cross-feeding interactions in the gut microbiome.
Reciprocal inflammatory signals establish profibrotic cross-feeding metabolism [young_old_bleo]
Gut microbiome repopulation through SCFA cross-feeding shapes community dynamics and alleviates IL-22–mediated colitis
A conserved cross-feeding mechanism drives microbial niche adaptation on leaf
Genomics
Vitamin metabolite cross-feeding
Sort   by:  
 Page size